No abstract available
Publication types
-
Randomized Controlled Trial
-
Clinical Trial, Phase II
MeSH terms
-
Antineoplastic Agents* / adverse effects
-
Colorectal Neoplasms*
-
Dietary Supplements
-
Humans
-
Incidence
-
Phenylurea Compounds / adverse effects
-
Pyridines*
-
Zinc / therapeutic use
Substances
-
regorafenib
-
Zinc
-
Phenylurea Compounds
-
Antineoplastic Agents
-
Pyridines